4ZOM
RORgamma in complex with inverse agonist 4j.
4ZOM の概要
エントリーDOI | 10.2210/pdb4zom/pdb |
分子名称 | Nuclear receptor ROR-gamma, N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide (3 entities in total) |
機能のキーワード | rorgamma inverse agonist, transcription |
由来する生物種 | Homo sapiens (Human) |
細胞内の位置 | Nucleus : P51449 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 106680.94 |
構造登録者 | |
主引用文献 | Wang, T.,Banerjee, D.,Bohnert, T.,Chao, J.,Enyedy, I.,Fontenot, J.,Guertin, K.,Jones, H.,Lin, E.Y.,Marcotte, D.,Talreja, T.,Van Vloten, K. Discovery of novel pyrazole-containing benzamides as potent ROR gamma inverse agonists. Bioorg.Med.Chem.Lett., 25:2985-2990, 2015 Cited by PubMed Abstract: The nuclear receptor RORγ plays a central role in controlling a pro-inflammatory gene expression program in several lymphocyte lineages including TH17 cells. RORγ-dependent inflammation has been implicated in the pathogenesis of several major autoimmune diseases and thus RORγ is an attractive target for therapeutic intervention in these diseases. Starting from a lead biaryl compound 4a, replacement of the head phenyl moiety with a substituted aminopyrazole group resulted in a series with improved physical properties. Further SAR exploration led to analogues (e.g., 4j and 5m) as potent RORγ inverse agonists. PubMed: 26048789DOI: 10.1016/j.bmcl.2015.05.028 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.27 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
